Rapport Therapeutics Inc
(RAPP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | |
| Cash Flows From Operating Activities | |
| Net Income | -10,652 |
| Depreciation Amortization | 15 |
| Other Working Capital | 1,488 |
| Other Operating Activity | 5,907 |
| Operating Cash Flow | $-3,242 |
| Cash Flows From Investing Activities | |
| PPE Investments | -284 |
| Other Investing Activity | -5,000 |
| Investing Cash Flow | $-5,284 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 39,685 |
| Financing Cash Flow | $39,685 |
| End Cash Position | 31,159 |
| Net Cash Flow | $31,159 |
| Free Cash Flow | |
| Operating Cash Flow | -3,242 |
| Free Cash Flow | -3,242 |